You are viewing the site in preview mode

Skip to main content
Fig. 2 | BMC Ophthalmology

Fig. 2

From: Long-term effects of intravitreal bevacizumab and aflibercept on intraocular pressure in wet age-related macular degeneration

Fig. 2

The time course of IOP (A) in treated versus fellow eyes during bevacizumab in non-switched patients, (B) bevacizumab in switched patients, (C) aflibercept in switched patients, and (D) in treated eyes only, comparing the three study groups. Plotted IOP data represent least squares means with 95% confidence intervals. Reported p-values describe the statistical significance of the interaction between time from baseline and treatment status (A - C), and time from baseline and study group (D)

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us